Molecular Diagnostics Market

1
Molecular Diagnostics Market to Reach USD 13.81
Billion By 2026
www.reportsanddata.com
sales_at_reportsanddata.com
2
Market Summary
Rising number of cancer cases, growing incidence
of infectious diseases, strong government funding
for medical science and the increasing
application of patient-specific treatments are
key factors contributing to high CAGR of
Molecular Diagnostics during the forecast
period. Market Size USD 7.28 Billion in 2018,
Market Growth - CAGR of 8.2, Market Trends
impressive growth in colorectal cancer molecular
diagnostics market According to the current
analysis of Reports and Data, the global
Molecular Diagnostics market was valued at USD
7.28 Billion in 2018 and is expected to reach USD
13.81 Billion by year 2026, at a CAGR of 8.2.
3
Our Approach
Market Summary

• The increasing efficiency of clinical trials,
  growing incidence of infectious and neurological
  diseases, and technological advancements in
  molecular pathology are major driving factors
  being the growth of the market. The increasing
  government aid for research and establishment of
  advanced testing facilities is also supporting
  the growth of the market.
• The developing economies of India and China face
  some challenges in the form of the lack of a
  well-built procedural system for approvals, which
  hinders the growth of the molecular diagnostics
  market. Moreover, a shortage of skilled medical
  professionals is also limiting the growth of the
  market in many countries.
• Request for a sample of this research report _at_
  https//www.reportsanddata.com/sample-enquiry-form
  /945

4
Our Approach
Market Summary

• Key Players Are Abbott, Roche Diagnostics,
  QIAGEN, Danaher, Hologic, Becton, Siemens
  Healthcare GmbH, Bio-Rad Laboratories, Dickinson
  and Co., Cepheid
• For the purpose of this report, Reports and Data
  has segmented the Molecular Diagnostics market on
  the basis of product and service, technology,
  application, end use, and region
• Product and Service (Revenue, USD Million
  20162026)
• Reagents and Kits
• Instruments
• Services and Software
• Technology (Revenue, USD Million 20162026)
• Polymerase Chain Reaction (PCR) 
• Isothermal Nucleic Acid Amplification Technology
  (INAAT) 
• DNA Sequencing Next-Generation Sequencing
  (NGS) 
• in Situ Hybridization 
• DNA Microarray 
• Other Technologies

5
Our Approach
Market Summary

• Application (Revenue, USD Million 20162026)
• Infectious Diseases
• Oncology
• Genetic Tests
• Others
• End Use (Revenue, USD Million 20162026)
• Hospital and Academic Laboratories
• Reference Laboratories
• Others
• Regional Outlook (Revenue in USD Million
  20162026)
• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America
• Order Now https//www.reportsanddata.com/checkout
  -form/945

6
About Us
Our Approach
About Us

• Reports and Data is a market research and
  consulting company that provides syndicated
  research reports, customized research reports,
  and consulting services. Our solutions purely
  focus on your purpose to locate, target and
  analyze consumer behavior shifts across
  demographics, across industries and help clients
  make a smarter business decision. We offer market
  intelligence studies ensuring relevant and
  fact-based research across a multiple industries
  including Healthcare, Technology, Chemicals,
  Power, and Energy. We consistently update our
  research offerings to ensure our clients are
  aware about the latest trends existent in the
  market. Reports and Data has a strong base of
  experienced analysts from varied areas of
  expertise.
• Contact Us
• John Watson
• Head of Business Development
• Reports And Data Web www.reportsanddata.com
• Direct Line 1-212-710-1370
• E-mail sales_at_reportsanddata.com